Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism HDAC inhibitors(Histone deacetylase inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC23H18N2O4 |
InChIKeyGVYGGRCEOHNFDZ-UHFFFAOYSA-N |
CAS Registry2762229-06-9 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Acanthamoeba Keratitis | Preclinical | KR | 17 Nov 2020 |